Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-12 19:07:11 UTC |
---|
Update Date | 2022-03-07 02:49:18 UTC |
---|
HMDB ID | HMDB0003339 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | D-Glutamic acid |
---|
Description | There are two forms of glutamic acid found in nature: L-glutamic acid and D-glutamic acid. D-glutamic acid, is not endogenously produced in higher mammals. It is found naturally primarily in the cell walls of certain bacteria. D-glutamate is also present in certain foods e.g., soybeans and also arises from the turnover of the intestinal tract microflora, whose cell walls contain significant D-glutamate. Unlike other D-amino acids, D-glutamate is not oxidized by the D-amino acid oxidases, and therefore this detoxification pathway is not available for handling D-glutamate. Likewise, D-glutamic acid, when ingested, largely escapes most deamination reactions (unlike the L-counterpart). Free D-glutamate is found in mammalian tissue at surprisingly high levels, with D-glutamate accounting for 9% of the total glutamate present in liver. D-glutamate is the most potent natural inhibitor of glutathione synthesis identified to date and this may account for its localization to the liver, since circulating D-glutamate may alter redox stabiity (PMID 11158923 ). Certain eels are known to use D-glutamic acid as a phermone for chemical communication. D-Glutamic acid has been found to be a metabolite of Lactobacillus (PMID: 22754309 ). |
---|
Structure | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(R)-2-Aminopentanedioic acid | ChEBI | D-2-Aminoglutaric acid | ChEBI | D-Glutaminic acid | ChEBI | D-Glutaminsaeure | ChEBI | DGL | ChEBI | Glutamic acid D-form | ChEBI | (R)-2-Aminopentanedioate | Generator | D-2-Aminoglutarate | Generator | D-Glutaminate | Generator | Glutamate D-form | Generator | D-Glutamate | Generator | (2R)-2-Aminopentanedioate | HMDB | (2R)-2-Aminopentanedioic acid | HMDB | D-2-Aminopentanedioate | HMDB | D-2-Aminopentanedioic acid | HMDB | delta-2-Aminoglutarate | HMDB | delta-2-Aminoglutaric acid | HMDB | delta-2-Aminopentanedioate | HMDB | delta-2-Aminopentanedioic acid | HMDB | delta-Glutamate | HMDB | delta-Glutamic acid | HMDB | delta-Glutaminate | HMDB | delta-Glutaminic acid | HMDB | delta-Glutaminsaeure | HMDB | Glutamate | HMDB | Lopac-g-2128 | HMDB | Lopac-gamma-2128 | HMDB | R-(-)-Glutamate | HMDB | R-(-)-Glutamic acid | HMDB | Tocris-0217 | HMDB | Glutamic acid, (D)-isomer | HMDB | L Glutamic acid | HMDB | L-Glutamate | HMDB | L-Glutamic acid | HMDB | D Glutamate | HMDB | Glutamate, potassium | HMDB | L-Glutamate, aluminum | HMDB | Aluminum L glutamate | HMDB | Glutamic acid | HMDB | L Glutamate | HMDB | Aluminum L-glutamate | HMDB | Potassium glutamate | HMDB |
|
---|
Chemical Formula | C5H9NO4 |
---|
Average Molecular Weight | 147.1293 |
---|
Monoisotopic Molecular Weight | 147.053157781 |
---|
IUPAC Name | (2R)-2-aminopentanedioic acid |
---|
Traditional Name | D-glutamic acid |
---|
CAS Registry Number | 6893-26-1 |
---|
SMILES | N[C@H](CCC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 |
---|
InChI Key | WHUUTDBJXJRKMK-GSVOUGTGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Glutamic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Glutamic acid or derivatives
- Alpha-amino acid
- D-alpha-amino acid
- Amino fatty acid
- Dicarboxylic acid or derivatives
- Fatty acid
- Fatty acyl
- Amino acid
- Carboxylic acid
- Organic oxide
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | Biological locationRoute of exposureSourceExogenousFood- Food (HMDB: HMDB0003339)
Milk and milk productUnfermented milk- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
Endogenous |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 201 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 8.88 mg/mL at 25 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
D-Glutamic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O | 1507.5 | Semi standard non polar | 33892256 | D-Glutamic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O | 1472.0 | Semi standard non polar | 33892256 | D-Glutamic acid,1TMS,isomer #3 | C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O | 1533.4 | Semi standard non polar | 33892256 | D-Glutamic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C | 1518.9 | Semi standard non polar | 33892256 | D-Glutamic acid,2TMS,isomer #2 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O | 1617.6 | Semi standard non polar | 33892256 | D-Glutamic acid,2TMS,isomer #3 | C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C | 1589.3 | Semi standard non polar | 33892256 | D-Glutamic acid,2TMS,isomer #4 | C[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C | 1729.5 | Semi standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1625.8 | Semi standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1664.7 | Standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1807.9 | Standard polar | 33892256 | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1779.5 | Semi standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1718.7 | Standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1969.6 | Standard polar | 33892256 | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1765.0 | Semi standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1708.5 | Standard non polar | 33892256 | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1949.2 | Standard polar | 33892256 | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1804.2 | Semi standard non polar | 33892256 | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1776.6 | Standard non polar | 33892256 | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1746.4 | Standard polar | 33892256 | D-Glutamic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O | 1765.9 | Semi standard non polar | 33892256 | D-Glutamic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O | 1743.3 | Semi standard non polar | 33892256 | D-Glutamic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O | 1797.0 | Semi standard non polar | 33892256 | D-Glutamic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1982.4 | Semi standard non polar | 33892256 | D-Glutamic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 2094.9 | Semi standard non polar | 33892256 | D-Glutamic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2043.8 | Semi standard non polar | 33892256 | D-Glutamic acid,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C | 2168.8 | Semi standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2272.6 | Semi standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2259.4 | Standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2195.4 | Standard polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2433.4 | Semi standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2321.6 | Standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2263.8 | Standard polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2427.8 | Semi standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2289.5 | Standard non polar | 33892256 | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2256.1 | Standard polar | 33892256 | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2668.5 | Semi standard non polar | 33892256 | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2533.6 | Standard non polar | 33892256 | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2243.6 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - D-Glutamic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0k9x-9300000000-a43e0122a45b9abf09d6 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - D-Glutamic acid GC-MS (2 TMS) - 70eV, Positive | splash10-00dl-9240000000-53c8c708191dfcd550d0 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - D-Glutamic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - D-Glutamic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , negative-QTOF | splash10-0002-0900000000-ad4a2989e599a67182c0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , negative-QTOF | splash10-0udi-0900000000-c449cfd2231fe941d44f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , negative-QTOF | splash10-0udi-1900000000-f71458032a132069f94f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , negative-QTOF | splash10-0udi-7900000000-810570c8cfcea8da64f5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-d5167570d11d77fd541e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , positive-QTOF | splash10-0002-0900000000-c7d42b011a328bb7991d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , positive-QTOF | splash10-001i-9300000000-9fd882f84339f600b5eb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , positive-QTOF | splash10-001i-9000000000-407a30a35de9c1cceb3a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , positive-QTOF | splash10-001i-9000000000-8610ea89d52ef116caf5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - D-Glutamic acid LC-ESI-QQ , positive-QTOF | splash10-0a4i-9000000000-331b7ed6ea33880c306e | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 10V, Positive-QTOF | splash10-001i-3900000000-58248bb2a0c7ddc905cf | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 20V, Positive-QTOF | splash10-0zgi-9600000000-076b628a6858a60a475f | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-bd3823a5fab8a2d9b62c | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 10V, Negative-QTOF | splash10-0002-1900000000-11233b5887638266e512 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 20V, Negative-QTOF | splash10-0fba-4900000000-1e8ea62e3fbd8467396f | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 40V, Negative-QTOF | splash10-0abc-9100000000-6c956e122b59de69a472 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 10V, Positive-QTOF | splash10-0f89-4900000000-c467fa409affedc9ab85 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 20V, Positive-QTOF | splash10-001i-9100000000-ddda6500978ea1670dcf | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-4c6639c8639f077b57a0 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 10V, Negative-QTOF | splash10-0059-4900000000-503f6a47bc72662de09c | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 20V, Negative-QTOF | splash10-0ugi-3900000000-ec06b29308ff068bf7a2 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - D-Glutamic acid 40V, Negative-QTOF | splash10-0006-9000000000-e06c31345e8a86e71de1 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Breast Milk
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - Epidermis
- Fibroblasts
- Intestine
- Neuron
- Placenta
- Spleen
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0140-0.200 uM | Adult (>18 years old) | Not Specified | Normal | | details | Breast Milk | Detected and Quantified | 1600 +/- 320 uM | Adult (>18 years old) | Female | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | Feces | Detected and Quantified | 880 +/- 680 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 490 +/- 390 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 11382 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | Feces | Detected and Quantified | 8923 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 11117 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 67.51 +/- 75.14 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 43.4 +/- 55.1 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 8.91 +/- 3.90 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 13.5 +/- 8.75 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 14.5 +/- 19.8 uM | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 14.5 +/- 6.75 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 14.9 +/- 7.60 uM | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 123.84 +/- 110.2 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 7.9 +/- 3.9 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 2.6 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 8.5 (3.3-18.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 82.0 +/- 8.0 uM | Infant (0-1 year old) | Both | Premature | | details | Blood | Detected and Quantified | 156.0 +/- 90.0 uM | Adult (>18 years old) | Both | Schizophrenia | | details | Blood | Detected and Quantified | 52.21 (14.83) uM | Adult (>18 years old) | Female | Pregnancy with fetus having congenital heart defect | | details | Blood | Detected and Quantified | 56.4 (12.69) uM | Adult (>18 years old) | Female | Pregnancy | | details | Blood | Detected and Quantified | 0.429 uM | Adult (>18 years old) | Not Specified | Gamma-glutamyltransferase deficiency | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Crohn’s Disease | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative Colitis | | details | Saliva | Detected and Quantified | 38.26 +/- 29.05 uM | Adult (>18 years old) | Male | Alzheimer's disease | | details | Saliva | Detected and Quantified | 43.79 +/- 10.57 uM | Adult (>18 years old) | Male | Frontotemporal lobe dementia | | details | Saliva | Detected and Quantified | 47.82 +/- 18.36 uM | Adult (>18 years old) | Both | Lewy body disease | | details | Urine | Detected and Quantified | 0.0064 umol/mmol creatinine | Adult (>18 years old) | Both | ADPKD | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Schizophrenia |
---|
- Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2. [PubMed:17276036 ]
| Pregnancy |
---|
- Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
| Gamma-glutamyltransferase deficiency |
---|
- Schulman JD, Goodman SI, Mace JW, Patrick AD, Tietze F, Butler EJ: Glutathionuria: inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochem Biophys Res Commun. 1975 Jul 8;65(1):68-74. [PubMed:238530 ]
| Crohn's disease |
---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Ulcerative colitis |
---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Colorectal cancer |
---|
- Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345. [PubMed:19006102 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
- Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762. [PubMed:27107423 ]
| Irritable bowel syndrome |
---|
- Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17. [PubMed:21330412 ]
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
| Alzheimer's disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Frontotemporal dementia |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Lewy body disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Autosomal dominant polycystic kidney disease |
---|
- Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
|
|
---|
Associated OMIM IDs | - 181500 (Schizophrenia)
- 266600 (Crohn's disease)
- 114500 (Colorectal cancer)
- 104300 (Alzheimer's disease)
- 600274 (Frontotemporal dementia)
- 601313 (Autosomal dominant polycystic kidney disease)
|
---|
External Links |
---|
DrugBank ID | DB02517 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023148 |
---|
KNApSAcK ID | C00019577 |
---|
Chemspider ID | 21814 |
---|
KEGG Compound ID | C00217 |
---|
BioCyc ID | D-GLT |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Glutamic acid |
---|
METLIN ID | 6895 |
---|
PubChem Compound | 23327 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 15966 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | GLU_D |
---|
MarkerDB ID | MDB00000422 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Ozaki, Akio; Yagasaki, Makoto; Takada, Hideyoshi; Hashimoto, Yukio. Manufacture of D-glutamic acid with Lactobacillus. Jpn. Kokai Tokkyo Koho (1990), 4 pp. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Emi M, Wilson DE, Iverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM: Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem. 1990 Apr 5;265(10):5910-6. [PubMed:1969408 ]
- Persson H, Pelto-Huikko M, Metsis M, Soder O, Brene S, Skog S, Hokfelt T, Ritzen EM: Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Mol Cell Biol. 1990 Sep;10(9):4701-11. [PubMed:1697032 ]
- Ahlman B, Andersson K, Leijonmarck CE, Ljungqvist O, Hedenborg L, Wernerman J: Short-term starvation alters the free amino acid content of the human intestinal mucosa. Clin Sci (Lond). 1994 Jun;86(6):653-62. [PubMed:7914846 ]
- Wang M, Meng Z, Fu J: Synthesis and biodistribution of six novel 99mTc complexes of 2-hydroxybenzaldehyde-amino acid Schiff bases. Appl Radiat Isot. 2006 Feb;64(2):235-40. [PubMed:16309915 ]
- Majid SM, Liss AS, You M, Bose HR: The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene. 2006 Feb 2;25(5):756-68. [PubMed:16186799 ]
- Canal N, Nemni R: Autoimmunity and diabetic neuropathy. Clin Neurosci. 1997;4(6):371-3. [PubMed:9358982 ]
- Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW: Autoreactive T cells in healthy individuals. J Immunol. 2004 May 15;172(10):5967-72. [PubMed:15128778 ]
- Guariso G, Brotto F, Basso D, Alaggio R, Betterle C: Organ-specific autoantibodies in children with Helicobacter pylori infection. Helicobacter. 2004 Dec;9(6):622-8. [PubMed:15610075 ]
- Nagai A, Suzuki Y, Baek SY, Lee KS, Lee MC, McLarnon JG, Kim SU: Generation and characterization of human hybrid neurons produced between embryonic CNS neurons and neuroblastoma cells. Neurobiol Dis. 2002 Oct;11(1):184-98. [PubMed:12460557 ]
- Mally MI, Cirulli V, Hayek A, Otonkoski T: ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia. 1996 Apr;39(4):474-80. [PubMed:8777998 ]
- Maechler P, Gjinovci A, Wollheim CB: Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas. Diabetes. 2002 Feb;51 Suppl 1:S99-102. [PubMed:11815466 ]
- Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST: No allelic variation in genes with high gliadin homology in patients with celiac disease and type 1 diabetes. Immunogenetics. 2004 Aug;56(5):375-8. Epub 2004 Aug 7. [PubMed:15309343 ]
- Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ: Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science. 2002 Oct 11;298(5592):425-9. [PubMed:12376704 ]
- Meyer W, Poehling HM, Neurand K: Intraepidermal distribution of free amino acids in porcine skin. J Dermatol Sci. 1991 Sep;2(5):383-92. [PubMed:1742249 ]
- Cuervo JH, Rodriguez B, Houghten RA: The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity. Pept Res. 1988 Nov-Dec;1(2):81-6. [PubMed:2980783 ]
- Roll U, Scheeser J, Standl E, Ziegler AG: Alterations of lymphocyte subsets in children of diabetic mothers. Diabetologia. 1994 Nov;37(11):1132-41. [PubMed:7867885 ]
- Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP: Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15;175(10):7029-37. [PubMed:16272364 ]
- Raj D, Langford M, Krueger S, Shelton M, Welbourne T: Regulatory responses to an oral D-glutamate load: formation of D-pyrrolidone carboxylic acid in humans. Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E214-20. [PubMed:11158923 ]
- Zareian M, Ebrahimpour A, Bakar FA, Mohamed AK, Forghani B, Ab-Kadir MS, Saari N: A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods. Int J Mol Sci. 2012;13(5):5482-97. doi: 10.3390/ijms13055482. Epub 2012 May 7. [PubMed:22754309 ]
|
---|